The Effect of Celecoxib on Neuroinflammation in MDD: PET Imaging of a Novel Treatment Target With [18F]FEPPA
Latest Information Update: 26 Nov 2023
At a glance
- Drugs Celecoxib (Primary)
- Indications Neurogenic inflammation
- Focus Therapeutic Use
- 20 Nov 2023 Planned End Date changed from 31 Jul 2023 to 31 Jul 2024.
- 20 Nov 2023 Planned primary completion date changed from 31 Jul 2023 to 31 Jul 2024.
- 24 Oct 2022 Planned primary completion date changed from 31 Jul 2022 to 31 Jul 2023.